Literature DB >> 9219741

Brain and skeletal muscle bioenergetic failure in familial hypobetalipoproteinaemia.

R Lodi1, R Rinaldi, A Gaddi, S Iotti, R D'Alessandro, N Scoz, M Battino, V Carelli, G Azzimondi, P Zaniol, B Barbiroli.   

Abstract

OBJECTIVE: To determine whether a multisystemic bioenergetic deficit is an underlying feature of familial hypobetalipoproteinaemia.
METHODS: Brain and skeletal muscle bioenergetics were studied by in vivo phosphorus MR spectroscopy (31P-MRS) in two neurologically affected members (mother and son) and in one asymptomatic member (daughter) of a kindred with familial hypobetalipoproteinaemia. Plasma concentrations of vitamin E and coenzyme Q10 (CoQ10) were also assessed.
RESULTS: Brain 31P-MRS disclosed in all patients a reduced phosphocreatine (PCr) concentration whereas the calculated ADP concentration was increased. Brain phosphorylation potential was reduced in the members by about 40%. Skeletal muscle was studied at rest in the three members and during aerobic exercise and recovery in the son and daughter. Only the mother showed an impaired mitochondrial function at rest. Both son and daughter showed an increased end exercise ADP concentration whereas the rates of postexercise recovery of PCr and ADP were slow in the daughter. The rate of inorganic phosphate recovery was reduced in both cases. Plasma concentration of vitamin E and CoQ10 was below the normal range in all members.
CONCLUSIONS: Structural changes in mitochondrial membranes and deficit of vitamin E together with reduced availability of CoQ10 can be responsible for the multisystemic bioenergetic deficit. Present findings suggest that CoQ10 supplementation may be important in familial hypobetalipoproteinaemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9219741      PMCID: PMC1074139          DOI: 10.1136/jnnp.62.6.574

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  45 in total

1.  Control of oxidative metabolism and oxygen delivery in human skeletal muscle: a steady-state analysis of the work/energy cost transfer function.

Authors:  B Chance; J S Leigh; B J Clark; J Maris; J Kent; S Nioka; D Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

2.  Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR.

Authors:  D L Arnold; P M Matthews; G K Radda
Journal:  Magn Reson Med       Date:  1984-09       Impact factor: 4.668

3.  Lack of tocopherol in peripheral nerves of vitamin E-deficient patients with peripheral neuropathy.

Authors:  M G Traber; R J Sokol; S P Ringel; H E Neville; C A Thellman; H J Kayden
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

4.  Long-term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency: a 31P NMR study.

Authors:  Y Nishikawa; M Takahashi; S Yorifuji; Y Nakamura; S Ueno; S Tarui; T Kozuka; T Nishimura
Journal:  Neurology       Date:  1989-03       Impact factor: 9.910

5.  Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine.

Authors:  S M Eleff; P B Barker; S J Blackband; J C Chatham; N W Lutz; D R Johns; R N Bryan
Journal:  Ann Neurol       Date:  1990-06       Impact factor: 10.422

6.  Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy.

Authors:  S Ogasahara; A G Engel; D Frens; D Mack
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

7.  Rapid, reliable in vivo assays of human phosphate metabolites by nuclear magnetic resonance.

Authors:  P A Bottomley; C J Hardy
Journal:  Clin Chem       Date:  1989-03       Impact factor: 8.327

8.  Multiple controls of oxidative metabolism in living tissues as studied by phosphorus magnetic resonance.

Authors:  B Chance; J S Leigh; J Kent; K McCully; S Nioka; B J Clark; J M Maris; T Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

9.  In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease.

Authors:  P M Matthews; C Allaire; E A Shoubridge; G Karpati; S Carpenter; D L Arnold
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

10.  Cerebral metabolism in hyper- and hypocarbia: 31P and 1H nuclear magnetic resonance studies.

Authors:  O A Petroff; J W Prichard; K L Behar; D L Rothman; J R Alger; R G Shulman
Journal:  Neurology       Date:  1985-12       Impact factor: 9.910

View more
  3 in total

1.  Mitochondrial coupling in humans: assessment of the P/O2 ratio at the onset of calf exercise.

Authors:  V Cettolo; M Cautero; E Tam; M P Francescato
Journal:  Eur J Appl Physiol       Date:  2007-01-06       Impact factor: 3.078

2.  Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.

Authors:  R Lodi; J M Cooper; J L Bradley; D Manners; P Styles; D J Taylor; A H Schapira
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

3.  Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q₁₀ effect on clinical improvement.

Authors:  Mario D Cordero; Francisco Javier Cano-García; Elísabet Alcocer-Gómez; Manuel De Miguel; José Antonio Sánchez-Alcázar
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.